Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Xultophy 100/3.6 for the Treatment of Type 2 Diabetes

Drug (Brand / Generic)

Xultophy 100/3.6

Product Description

Anti-hyperglycemic agent

Current Indication

Type 2 diabetes

Developer

Novo Nordisk

Development Status

Approved in the US and Europe
Expand

Go Top